Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 1,029.294 million compared to CNY 741.841 million a year ago. Operating income was CNY 247.481 million compared to CNY 93.015 million a year ago. Net income was CNY 227.357 million compared to CNY 112.129 million a year ago. Basic earnings per share was CNY 0.25 compared to CNY 0.12 a year ago.